CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Yabao Pharmaceutical Group Company Limited Company Snapshot
Yabao Pharmaceutical Group Company Limited operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Yabao Pharmaceutical Group Company Limited with three other companies in this sector in China: Shanxi Zhendong Pharmaceutical Co Ltd (2015 sales of 2.26 billion Chinese Renmimbi [US$329.97 million] of which 95% was Medicine Manufacture and Sale), Zhejiang Jianfeng Group Company Limited (2.26 billion Chinese Renmimbi [US$329.37 million] of which 45% was Pharmaceutical), and PKU HealthCare Corp Ltd (2.01 billion Chinese Renmimbi [US$293.30 million] of which 63% was Merchandise&Material Selling).

Sales Analysis. Yabao Pharmaceutical Group Company Limited reported sales of 2.07 billion Chinese Renmimbi (US$301.26 million) for the year ending December of 2015. This represents an increase of 9.3% versus 2014, when the company's sales were 1.89 billion Chinese Renmimbi. This was the third consecutive year of growth at Yabao Pharmaceutical Group Company Limited. Sales of Other Operations saw an increase that was more than double the company's growth rate: sales were up 80.8% in 2015, from 6.98 million Chinese Renmimbi to 12.62 million Chinese Renmimbi. Yabao Pharmaceutical Group Company Limited also saw significant increases in sales in Pharmaceutical Wholesale (up 66.4% to 395.12 million Chinese Renmimbi) . Not all segments of Yabao Pharmaceutical Group Company Limited experienced an increase in sales in 2015: sales of Other fell 69.1% to 10.48 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Yabao Pharmaceutical Group Company Limited
  Stock Performance Chart for Yabao Pharmaceutical Group Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 9.49
(Figures in Chinese Renmimbi)
1 Week -2.5%   13 Weeks -1.6%  
4 Weeks -5.1%   52 Weeks -20.2%  
 
Yabao Pharmaceutical Group Company Limited Key Data:
  Ticker: 600351 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2015 Sales 2,065,108,293
(Year Ending Jan 2016).
Employees: 6,066
  Currency: Chinese Renmimbi Market Cap: 7,469,023,465
  Fiscal Yr Ends: December Shares Outstanding: 787,041,461
  Share Type: A Gu Closely Held Shares: 296,153,693
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.